Plethico Pharmaceuticals Ltd Quarterly Results

Gross Sales

113.58

108.2

260.5

275.66

313.02

Excise Duty

0

0

0

0

0

Net Sales

113.58

108.2

260.5

275.66

313.02

Other Operating Income

-0.74

3.25

2.46

2.22

-2.79

Other Income

-0.15

0.13

0.43

-0.4

0

Total Income

112.69

111.58

263.39

277.47

310.22

Total Expenditure

439.68

93.11

211.32

227.23

261.74

PBIDT

-326.99

18.46

52.08

50.24

48.49

Interest

21.6

11.7

51.99

36.25

57.02

PBDT

-348.59

6.76

0.08

13.99

-8.53

Depreciation

16.43

10.82

15.42

15.24

15.79

Minority Interest Before NP

0

0

0

0

0

Tax

-99.34

0

-9.02

0.43

-12.33

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

-265.67

-4.07

-6.31

-1.68

-11.98

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-265.67

-4.07

-6.31

-1.68

-11.98

Extra-ordinary Items

-319.56

0

0

0

0

Adjusted Profit After Extra-ordinary item

53.89

-4.07

-6.31

-1.68

-11.98

EPS (Unit Curr.)

-77.99

-1.19

-1.85

-0.49

-3.52

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

34.07

34.07

34.07

34.07

34.07

Public Shareholding (Number)

96,45,975

96,45,975

96,50,237

93,35,737

89,65,737

Public Shareholding (%)

28.31

28.31

28.33

27.4

26.32

Pledged/Encumbered - No. of Shares

2,09,37,385

2,09,37,385

2,09,37,384

2,12,51,884

2,16,21,885

Pledged/Encumbered - % in Total Promoters Holding

85.74

85.74

85.75

85.93

86.14

Pledged/Encumbered - % in Total Equity

61.46

61.46

61.46

62.39

63.47

Non Encumbered - No. of Shares

34,83,307

34,83,307

34,79,045

34,79,045

34,79,045

Non Encumbered - % in Total Promoters Holding

14.26

14.26

14.25

14.07

13.86

Non Encumbered - % in Total Equity

10.22

10.22

10.21

10.21

10.21

PBIDTM(%)

-287.89

17.06

19.99

18.22

15.49

PBDTM(%)

-306.91

6.24

0.03

5.07

-2.72

PATM(%)

-233.9

-3.76

-2.42

-0.6

-3.82